Building off of pivotal APDA-funded work highlighted...see more
Taking Parkinson’s education to the farmers market: educating under-served communities
Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian...see more
New medication, Istradefylline, gets approved for Parkinson’s disease
On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval...see more
APDA Seed Funding Leads to Prestigious NIH Research Grant
APDA is exceptionally proud to congratulate Dr. Beom-Chan Lee, APDA Research...see more
APDA-funded research finds new role for alpha-synuclein
This new understanding of alpha-synuclein’s function could open up new ways of thinking...see more
Merck announces its decision to stop the manufacturing of Sinemet CR
Merck has informed the Food and Drug Administration (FDA)...see more
Bill Rasmussen, founder of ESPN, diagnosed with Parkinson’s disease
Bill Rasmussen, founder of ESPN, shares his Parkinson's disease diagnoses.
$52 billion per year is spent on PD-related expenses, according to results of the Economic Burden of Parkinson’s Disease Study
$52 billion per year is spent on PD-related expenses, according to results of the Economic Burden of Parkinson’s Disease...see more
Recently published results of a GDNF intraputaminal infusion clinical trial
A clinical trial, is by definition an experiment or a test — an effort to determine if something works,...see more
FDA Approves Inbrija™ (levodopa inhalation powder) Parkinson’s disease
FDA Approves Inbrija™ (levodopa inhalation powder) December 22, 2018 Acorda Therapeutics announced the FDA approval of INBRIJA™ (levodopa inhalation powder)...see more